SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-027829
Filing Date
2019-05-08
Accepted
2019-05-08 16:32:47
Documents
51
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a19-7578_110q.htm 10-Q 758403
2 EX-31.1 a19-7578_1ex31d1.htm EX-31.1 11326
3 EX-31.2 a19-7578_1ex31d2.htm EX-31.2 11351
4 EX-32.1 a19-7578_1ex32d1.htm EX-32.1 7560
  Complete submission text file 0001104659-19-027829.txt   4523916

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT espr-20190331.xml EX-101.INS 1088359
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20190331.xsd EX-101.SCH 29718
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT espr-20190331_cal.xml EX-101.CAL 45025
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT espr-20190331_lab.xml EX-101.LAB 366399
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20190331_pre.xml EX-101.PRE 245276
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT espr-20190331_def.xml EX-101.DEF 126416
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35986 | Film No.: 19807116
SIC: 2834 Pharmaceutical Preparations